Henry DS, Pellegrino RG. A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease
and related dementias among male and female patients aged 65 years and older
supporting the need for a phase III clinical trial. PLoS One 2023;18:e0292863.
PMID: 37851623